891 related articles for article (PubMed ID: 22017778)
1. Cardiac amyloidosis: a practical approach to diagnosis and management.
Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
[TBL] [Abstract][Full Text] [Related]
2. Cardiac amyloidosis: an approach to diagnosis and management.
Halwani O; Delgado DH
Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):1007-13. PubMed ID: 20602561
[TBL] [Abstract][Full Text] [Related]
3. Current trends in diagnosis and management of cardiac amyloidosis.
Esplin BL; Gertz MA
Curr Probl Cardiol; 2013 Feb; 38(2):53-96. PubMed ID: 23337445
[TBL] [Abstract][Full Text] [Related]
4. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
5. [Cardiac amyloidosis].
Hoyer C; Angermann CE; Knop S; Ertl G; Störk S
Med Klin (Munich); 2008 Mar; 103(3):153-60. PubMed ID: 18344065
[TBL] [Abstract][Full Text] [Related]
6. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
7. Heart failure and cardiac involvement as isolated manifestation of familial form of transthyretin amyloidosis resulting from Val30Met mutation with no clinical signs of polyneuropathy.
Christoph DC; Boese D; Johnson KT; Schlosser TW; Hunold P; Baba HA; Erbel R; Philipp S
Circ Heart Fail; 2009 Sep; 2(5):512-5. PubMed ID: 19808383
[No Abstract] [Full Text] [Related]
8. Recent advances in the diagnosis and management of cardiac amyloidosis.
Sher T; Gertz MA
Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
[TBL] [Abstract][Full Text] [Related]
9. Cardiac manifestations of amyloid disease.
Rivera RJ; Vicenty S
Bol Asoc Med P R; 2008; 100(4):60-70. PubMed ID: 19400531
[TBL] [Abstract][Full Text] [Related]
10. [Progress in the diagnosis and treatment of cardiac amyloidosis].
Jurczyszyn A; Engel A; Rajzer M; Czepiel J; Mazurs G
Przegl Lek; 2014; 71(6):340-5. PubMed ID: 25344976
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin-related amyloidoses and the heart: a clinical overview.
Rapezzi C; Quarta CC; Riva L; Longhi S; Gallelli I; Lorenzini M; Ciliberti P; Biagini E; Salvi F; Branzi A
Nat Rev Cardiol; 2010 Jul; 7(7):398-408. PubMed ID: 20479782
[TBL] [Abstract][Full Text] [Related]
12. Amyloid heart disease: a brief review of treatment options.
Dubrey SW
Postgrad Med J; 2012 Dec; 88(1046):700-5. PubMed ID: 22745180
[TBL] [Abstract][Full Text] [Related]
13. Cardiac amyloidosis: heterogenous pathogenic backgrounds.
Ikeda S
Intern Med; 2004 Dec; 43(12):1107-14. PubMed ID: 15645642
[TBL] [Abstract][Full Text] [Related]
14. New insights into systemic amyloidosis: the importance of diagnosis of specific type.
Picken MM
Curr Opin Nephrol Hypertens; 2007 May; 16(3):196-203. PubMed ID: 17420662
[TBL] [Abstract][Full Text] [Related]
15. [Heart failure in amyloidosis--a rare but treatable disease].
Ohlsson M; Oldfors A; Hallgren P
Lakartidningen; 2002 May; 99(21):2386-8, 2391. PubMed ID: 12090165
[TBL] [Abstract][Full Text] [Related]
16. Understanding and recognizing cardiac amyloidosis.
McVeigh T; Tennyson C
JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the noninvasive strategies of cardiac amyloidosis.
Zhao L; Fang Q
Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
[TBL] [Abstract][Full Text] [Related]
18. Cardiac amyloidosis: approaches to diagnosis and management.
Desai HV; Aronow WS; Peterson SJ; Frishman WH
Cardiol Rev; 2010; 18(1):1-11. PubMed ID: 20010333
[TBL] [Abstract][Full Text] [Related]
19. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry.
Olson LJ; Gertz MA; Edwards WD; Li CY; Pellikka PA; Holmes DR; Tajik AJ; Kyle RA
N Engl J Med; 1987 Sep; 317(12):738-42. PubMed ID: 3627183
[TBL] [Abstract][Full Text] [Related]
20. Direct tissue evaluation via immunofluorescence: in the diagnosis of hereditary transthyretin cardiac amyloidosis.
Fradley MG; Thakuria JV; Collins AB; Moore SA; Stone JR
Tex Heart Inst J; 2012; 39(1):71-5. PubMed ID: 22412233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
